{"database": "openregs", "table": "hearing_witnesses", "rows": [[24352, "CHRG-109hhrg29726", "and it was signed into law by President Bush on July 21", "", "2004. Project BioShield enables the Government to develop, procure, and make available countermeasures to chemical, biological, radiological, and nuclear agents for use in a public health emergency that affects national security. Pharmaceutical research and development historically has focused on development of products likely to attract significant commercial interest. Many countermeasures for potential agents of terrorism realistically h", "2004. PROJECT BIOSHIELD ENABLES THE GOVERNMENT TO DEVELOP, PROCURE, AND MAKE AVAILABLE COUNTERMEASURES TO CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR AGENTS FOR USE IN A PUBLIC HEALTH EMERGENCY THAT AFFECTS NATIONAL SECURITY. PHARMACEUTICAL RESEARCH AND DEVELOPMENT HISTORICALLY HAS FOCUSED ON DEVELOPMENT OF PRODUCTS LIKELY TO ATTRACT SIGNIFICANT COMMERCIAL INTEREST. MANY COUNTERMEASURES FOR POTENTIAL AGENTS OF TERRORISM REALISTICALLY H", ""]], "columns": ["id", "package_id", "name", "title", "organization", "organization_normalized", "location"], "primary_keys": ["id"], "primary_key_values": ["24352"], "units": {}, "query_ms": 0.41625602170825005, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}